Press Releases from Tosymra - Pharma Proff (1 total)
Tosymra - Drug Insight and Forecast, 2018
Tosymra, previously known as DFN-02, an intranasal spray containing sumatriptan (10 mg) and a 5-HT1B/1D receptor agonist developed by Dr. Reddy’s Laboratories Limited and its…
Go To Page:
